SynthesisFrontiers in pharmacology2022

Rituximab for the treatment of connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis.

Linrui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.